Todd C Brady Insider Trading $SBPH F-star Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Todd C Brady.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Todd C Brady. Todd C Brady is President and CEO in Aldeyra Therapeutics, Inc. ($ALDX) and Director in Evoke Pharma Inc ($EVOK) and Director in Spring Bank Pharmaceuticals, Inc. ($SBPH) and in Oncobiologics, Inc. ($ONS) and Director in Oncobiologics, Inc. ($ONS).
Todd C Brady in F-star Therapeutics, Inc.
Trading Symbol: SBPHIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Todd C Brady: Director
Holdings: 60,016 shares
Current Value: $450,120
Latest Transaction: Oct 01 2020
$SBPH Market Capitalization: $58.25M
$SBPH Previous Close: $7.50
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Todd C Brady in F-star Therapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALDX, EVOK, SBPH, OTLKW
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 01 2020 | SBPH | Spring Bank Pharma ... | Brady Todd C | Director | Grant | A | 0.00 | 9,235 | 0 | 60,016 | 50.8 K to 60 K (+18.19 %) |
Jul 01 2020 | SBPH | Spring Bank Pharma ... | Brady Todd C | Director | Grant | A | 0.00 | 8,418 | 0 | 50,781 | 42.4 K to 50.8 K (+19.87 %) |
Jun 25 2020 | SBPH | Spring Bank Pharma ... | Brady Todd C | Director | Option Exercise | A | 1.60 | 7,500 | 12,000 | 7,500 | |
Apr 01 2020 | SBPH | Spring Bank Pharma ... | Brady Todd C | Director | Grant | A | 0.00 | 13,306 | 0 | 42,363 | 29.1 K to 42.4 K (+45.79 %) |
Jan 02 2020 | SBPH | Spring Bank Pharma ... | Brady Todd C | Director | Grant | A | 0.00 | 7,832 | 0 | 29,057 | 21.2 K to 29.1 K (+36.90 %) |
Oct 01 2019 | SBPH | Spring Bank Pharma ... | Brady Todd C | Director | Grant | A | 0.00 | 3,597 | 0 | 21,225 | 17.6 K to 21.2 K (+20.41 %) |
Oct 01 2019 | SBPH | Spring Bank Pharma ... | Brady Todd C | Director | Grant | A | 0.00 | 3,597 | 0 | 21,225 | 17.6 K to 21.2 K (+20.41 %) |
Jul 11 2019 | SBPH | Spring Bank Pharma ... | Brady Todd C | Director | Option Exercise | A | 4.62 | 7,500 | 34,650 | 7,500 | |
Jul 01 2019 | SBPH | Spring Bank Pharma ... | Brady Todd C | Director | Grant | A | 0.00 | 3,354 | 0 | 17,628 | 14.3 K to 17.6 K (+23.50 %) |
Jun 19 2018 | SBPH | Spring Bank Pharma ... | Brady Todd C | Director | Option Exercise | A | 13.99 | 5,500 | 76,945 | 5,500 | |
Jun 16 2017 | SBPH | Spring Bank Pharma ... | Brady Todd C | Director | Option Exercise | A | 14.27 | 5,500 | 78,485 | 5,500 | |
Nov 23 2016 | SBPH | Spring Bank Pharma ... | Brady Todd C | Director | Option Exercise | A | 10.79 | 10,964 | 118,302 | 10,964 | |
Nov 23 2016 | SBPH | Spring Bank Pharma ... | Brady Todd C | Director | Grant | A | 9.12 | 10,964 | 99,992 | 10,964 | 0 to 11 K |
Jul 29 2016 | SBPH | Spring Bank Pharma ... | Brady Todd C | Director | Option Exercise | A | 9.05 | 11,000 | 99,550 | 11,000 |
Page: 1